CA
Crumly & Associates’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,111
| Closed | -$408K | – | 179 |
|
|
2025
Q1 | $408K | Buy |
16,111
+3,389
| +27% | +$85.9K | 0.11% | 107 |
|
|
2024
Q4 | $338K | Buy |
12,722
+1,942
| +18% | +$51.5K | 0.09% | 116 |
|
|
2024
Q3 | $312K | Sell |
10,780
-215
| -2% | -$6.22K | 0.09% | 120 |
|
|
2024
Q2 | $308K | Buy |
10,995
+2,998
| +37% | +$83.9K | 0.09% | 118 |
|
|
2024
Q1 | $222K | Buy |
7,997
+698
| +10% | +$19.4K | 0.06% | 127 |
|
|
2023
Q4 | $210K | Sell |
7,299
-9,891
| -58% | -$285K | 0.06% | 123 |
|
|
2023
Q3 | $570K | Buy |
17,190
+109
| +0.6% | +$3.62K | 0.22% | 63 |
|
|
2023
Q2 | $627K | Sell |
17,081
-3,136
| -16% | -$115K | 0.25% | 57 |
|
|
2023
Q1 | $825K | Buy |
20,217
+285
| +1% | +$11.6K | 0.36% | 45 |
|
|
2022
Q4 | $1.02M | Sell |
19,932
-133
| -0.7% | -$6.82K | 0.39% | 34 |
|
|
2022
Q3 | $878K | Sell |
20,065
-176
| -0.9% | -$7.7K | 0.36% | 38 |
|
|
2022
Q2 | $1.06M | Buy |
20,241
+773
| +4% | +$40.5K | 0.44% | 36 |
|
|
2022
Q1 | $1.01M | Buy |
19,468
+471
| +2% | +$24.4K | 0.38% | 44 |
|
|
2021
Q4 | $1.01M | Buy |
18,997
+126
| +0.7% | +$6.73K | 0.4% | 45 |
|
|
2021
Q3 | $812K | Sell |
18,871
-4,016
| -18% | -$173K | 0.38% | 48 |
|
|
2021
Q2 | $896K | Buy |
22,887
+1,452
| +7% | +$56.8K | 0.43% | 42 |
|
|
2021
Q1 | $777K | Buy |
21,435
+4,985
| +30% | +$181K | 0.45% | 40 |
|
|
2020
Q4 | $601K | Buy |
16,450
+623
| +4% | +$22.8K | 0.42% | 36 |
|
|
2020
Q3 | $581K | Buy |
+15,827
| New | +$581K | 0.5% | 27 |
|